Vital Signs Podcast: Clever Culture Systems shift to big pharma clients is perfect prescription
Health & Biotech
share
Vital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist Nadine McGrath.
In this episode Nadine chats to Brent Barnes CEO and managing director of Clever Culture Systems (ASX:CC5), which provides intelligent automation solutions to microbiology laboratories.
Based in Adelaide, the company has developed a best-in-class technology, the Automated Plate Assessment System, using artificial intelligence and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates.
The industry is expected to reach more than US$1 billion over the next five years.
Listen to Nadine and Brent discuss environmental monitoring, how Clever Culture Systems is improving this process for big pharma and what is in store for the company for the rest of 2025.
This podcast was developed in collaboration with Clever Culture Systems, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
